British News Agency

U.S. President Donald Trump provided information on medical innovations, reform processes related to veterans’ health, and ibogaine research.

Detailing the scope of the reform, Trump said: “We are announcing historic reforms that will significantly accelerate access to new medical research and treatments based on psychedelic drugs.”

Referring to veterans and scientific data, Trump stated: “Since September 11, we see that 21 times more veterans have died by suicide than those killed on the battlefield, and today we are bringing them new hope.”

Trump added: “In a 2024 Stanford University study, 30 special operations veterans with traumatic brain injury received ibogaine treatment and experienced an 80–90% reduction in depression and anxiety symptoms within one month.”

Speaking about financial investments and legal processes, Trump said: “Today, the federal government is investing $50 million in ibogaine research. We are also opening a pathway for the use of ibogaine in critically ill patients under the ‘Right to Try’ law.”